Posted On: 08/11/2013 4:48:12 PM
Post# of 5066
I have had a number of people ask me my position on complaining to the SEC in attempt to have them force Koos to allow for a shareholder vote on the A/S increase.
I am vehemently opposed to doing such. I think drawing this kind of negative attention to the stock and company would be not just counter-productive but dangerous.
The chances of the SEC forcing the company to modify the voting power structure in this case are slim and none. Plus, I don't see why the SEC would feel a need to get involved; the increase of the A/S poses no threat to its shareholders and is a means to allow the company to continue on its path of providing a future substantial return to its shareholders by way of milestone payments for a one-of-a-kind cancer treatment that will make its way into the world of a 1.1 trillion dollar market. There is no legitimate argument from a legal standpoint.
Let's say the SEC's does entertain pursuing the matter on behalf of a few disgruntled shareholders on a claim that will not come to fruition. The aggravation of hiring counsel to defend against the claim will only cause thousands or tens of thousands in expenses the company does not need. Not to mention the headaches that are not needed at this very sensitive area in their timeline of seeing all of their efforts come to fruition.
Then there is further instability to the current pps while the manipulators and basher's have more ways to play during the speculation and uncertainty.
The thought of all this is unbelievable to me.
That is my position and I stand firm. Take it for what it's worth.
I am vehemently opposed to doing such. I think drawing this kind of negative attention to the stock and company would be not just counter-productive but dangerous.
The chances of the SEC forcing the company to modify the voting power structure in this case are slim and none. Plus, I don't see why the SEC would feel a need to get involved; the increase of the A/S poses no threat to its shareholders and is a means to allow the company to continue on its path of providing a future substantial return to its shareholders by way of milestone payments for a one-of-a-kind cancer treatment that will make its way into the world of a 1.1 trillion dollar market. There is no legitimate argument from a legal standpoint.
Let's say the SEC's does entertain pursuing the matter on behalf of a few disgruntled shareholders on a claim that will not come to fruition. The aggravation of hiring counsel to defend against the claim will only cause thousands or tens of thousands in expenses the company does not need. Not to mention the headaches that are not needed at this very sensitive area in their timeline of seeing all of their efforts come to fruition.
Then there is further instability to the current pps while the manipulators and basher's have more ways to play during the speculation and uncertainty.
The thought of all this is unbelievable to me.
That is my position and I stand firm. Take it for what it's worth.
(0)
(0)
